Status:
COMPLETED
Evaluation of the Veriton SPECT/CT System
Lead Sponsor:
Mayo Clinic
Conditions:
Focus of Study is Comparison of 2 Types of Gamma Cameras
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The main purpose of this study is to evaluate a new type of gamma camera (the Veriton system) that provides a significant gain in system sensitivity and improved image quality compared to a convention...
Eligibility Criteria
Inclusion
- Adults age 18 years or older.
- Currently scheduled to undergo a nuclear medicine exam.
Exclusion
- Individuals under 18 years of age.
- Unwilling/unable to sign an informed consent form.
- Unable to lie on a Veriton imaging table for up to 40 minutes.
Key Trial Info
Start Date :
January 20 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2025
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT04722185
Start Date
January 20 2021
End Date
December 31 2025
Last Update
January 5 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905